Quantitative-profiling of neurotransmitter abnormalities in the disease progression of experimental diabetic encephalopathy rat

Inhibition of Acetylcholinesterase (AChE): A Potential Therapeutic Target to Treat Alzheimer's Disease

(2015) Yong Li et al.   Chemical Biology & Drug Design

SIRT1 Deficiency in Microglia Contributes to Cognitive Decline in Aging and Neurodegeneration via Epigenetic Regulation of IL-1 

(2015) S.-H. Cho et al.   JOURNAL OF NEUROSCIENCE

Central activation of PPAR-gamma ameliorates diabetes induced cognitive dysfunction and improves BDNF expression

(2015) Thiruchelvam Kariharan et al.   NEUROBIOLOGY OF AGING

GABAergic system in the endocrine pancreas: a new target for diabetes treatment

(2015) Qinghua Wang et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Pharmacological approaches for Alzheimer’s disease: neurotransmitter as drug targets

(2014) Atish Prakash et al.   Expert Review of Neurotherapeutics

L-type calcium channel blocker ameliorates diabetic encephalopathy by modulating dysregulated calcium homeostasis

(2014) Kirti Singhal et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Amelioration of Diabetes-induced Cognitive Deficits by GSK-3β Inhibition is Attributed to Modulation of Neurotransmitters and Neuroinflammation

(2014) Ashok Kumar Datusalia et al.   MOLECULAR NEUROBIOLOGY

Decreased Occipital Cortical Glutamate Levels in Response to Successful Cognitive-Behavioral Therapy and Pharmacotherapy for Major Depressive Disorder

(2014) Chadi G. Abdallah et al.   PSYCHOTHERAPY AND PSYCHOSOMATICS

A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: Effect on inflammation, psychopathology, cognition and lipid metabolism

(2014) Brenda Vincenzi et al.   SCHIZOPHRENIA RESEARCH

Activation of the canonical nuclear factor-κB pathway is involved in isoflurane-induced hippocampal interleukin-1β elevation and the resultant cognitive deficits in aged rats

(2013) Zheng-Qian Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Long-Term IKK2/NF- B Signaling in Pancreatic  -Cells Induces Immune-Mediated Diabetes

(2013) H. H. Salem et al.   DIABETES

Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington's disease like symptoms in rats: Behavioral, biochemical, cellular and histological evidences

(2013) Anil Kumar et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Expression of Glutamate Decarboxylase (GAD) mRNA in the Brain of Bile Duct Ligated Rats Serving as a Model of Hepatic Encephalopathy

(2013) Renata Leke et al.   NEUROCHEMICAL RESEARCH

Amelioration of diabetes-induced neurobehavioral and neurochemical changes by melatonin and nicotinamide: Implication of oxidative stress–PARP pathway

(2013) Ashok Jangra et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Suppression of methylglyoxal hyperactivity by mangiferin can prevent diabetes-associated cognitive decline in rats

(2013) Yao-Wu Liu et al.   PSYCHOPHARMACOLOGY

The PredictAD project: development of novel biomarkers and analysis software for early diagnosis of the Alzheimer's disease

(2013) K. Antila et al.   Interface Focus

Tau pathology induces loss of GABAergic interneurons leading to altered synaptic plasticity and behavioral impairments

(2013) Josien Levenga et al.   Acta Neuropathologica Communications

Quantitative Analysis of Neurochemical Panel in Rat Brain and Plasma by Liquid Chromatography–Tandem Mass Spectrometry

(2012) Xiao Zheng et al.   ANALYTICAL CHEMISTRY

Diabetes and cognitive dysfunction

(2012) Rory J McCrimmon et al.   LANCET

Loss of functional GABAA receptors in the Alzheimer diseased brain

(2012) A. Limon et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ginsenoside Re attenuates diabetes-associated cognitive deficits in rats

(2011) Yao-Wu Liu et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

The contribution of GABAergic dysfunction to neurodevelopmental disorders

(2011) Kartik Ramamoorthi et al.   TRENDS IN MOLECULAR MEDICINE

NF-κB inhibitory action of resveratrol: A probable mechanism of neuroprotection in experimental diabetic neuropathy

(2010) Ashutosh Kumar et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Immune modulation of learning, memory, neural plasticity and neurogenesis

(2010) Raz Yirmiya et al.   BRAIN BEHAVIOR AND IMMUNITY

Amyloid β oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors

(2010) Elena Alberdi et al.   CELL CALCIUM

Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades

(2010) Geeta Negi et al.   JOURNAL OF PINEAL RESEARCH

Choline-deprivation alters crucial brain enzyme activities in a rat model of diabetic encephalopathy

(2010) Charis Liapi et al.   METABOLIC BRAIN DISEASE

Dopamine Modulates Cholinergic Cortical Excitability in Alzheimer's Disease Patients

(2009) Alessandro Martorana et al.   NEUROPSYCHOPHARMACOLOGY

Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes

(2009) Bjoern A. Menge et al.   REGULATORY PEPTIDES

Tissue specificity of mitochondrial glutamate pathways and the control of metabolic homeostasis

(2008) Francesca Frigerio et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Cognitive Dysfunction and Diabetes Mellitus

(2008) Christopher T. Kodl et al.   ENDOCRINE REVIEWS

Cognition and diabetes: a lifespan perspective

(2008) Geert Jan Biessels et al.   LANCET NEUROLOGY

Vanadium improves brain acetylcholinesterase activity on early stage alloxan-diabetic rats

(2008) Doaa A. Ghareeb et al.   NEUROSCIENCE LETTERS